Abstract:Individuals actively infected with respiratory viruses, such as influenza A virus (IAV), respiratory syncytial virus (RSV), and coronaviruses, transmit by shedding droplets containing live virus while coughing, sneezing, or talking. Respiratory viruses subsequently enter the airways of a host either by coming in direct contact with aerosolized droplets or by an interaction with fomites [1]. The majority of respiratory virus infections are contained to the upper airways and self-limiting; however, lower respiratory tract infections (LRTIs) are a significant cause of morbidity and mortality, especially in children and the elderly [2,3]. When infiltration into the lower airways occurs, infectious viral particles encounter lung resident alveolar macrophages (AMφ). AMφ are self-renewing fetal-derived sentinel cells present in the airways that are tethered to the lung epithelium through αvβ6 integrin-latent TGF-β binding [4,5]. Upon direct interaction with viral particles, pro-inflammatory cytokines, or pattern/danger-associated molecular patterns (PAMPs/DAMPs), AMφ detach from the respiratory epithelium resulting in the induction of increased effector functions and phagocytosis as well as the up-regulation of type I interferons (IFN), chemokines, and pro-inflammatory cytokines [6–8]. AMφ express a myriad of pattern recognition receptors, including multiple toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) that sense viral genetic material and proteins driving NF-κB activation, type I IFN production, and the release of pro-inflammatory cytokines [9]. Early during infection, virus utilization of TLRs as attachment receptors, such as TLR4, as well as other molecules with signaling capacity have been shown to drive innate activation [10]. Intracellular sensors responding to the viral genome including MDA5/RIG-I and TLRs 3, 7, and 8, also mediate activation signals [11]. This early "danger alarm" response by AMφ is critical to the initiation of the innate immune response within the lung resulting in increased neutrophil and mononuclear cell infiltration and the induction of the antiviral IFN response pathways [6–8]. In vivo depletion of AMφ resulted in significantly increased disease and mortality in IAV-infected mice [7]. AMφ activation and pro-inflammatory cytokine production played a critical role in the activation of the immune system and RSV infection. Clodronate liposome depletion of AMφ prior to infection significantly reduced RSV-induced TNF, IL-6, IFNα, and chemokine production in the lung [8]. AMφ-depleted mice also exhibited significantly increased RSV-induced airway hyperreactivity as compared to controls [12]. Interestingly, AMφ significantly contributed to the induction of severe disease and immunopathology following human metapneumovirus (hMPV) infection. AMφ depletion ameliorated hMPV-induced disease and reduced lung inflammation suggesting excess pro-inflammatory responses contribute to disease [12]. Additionally, AMφ are essential to the resolution of inflammation and return to a homeostatic state without which severe immunopathology and lung damage can occur [13]. This highlights the multifaceted ability of AMφ to protect the respiratory epithelium and initiate the innate immune response while also playing an essential role in tissue damage control.

Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury

Extracellular Atp is A Danger Signal Activating P2x(7) Receptor in Lung Inflammation and Fibrosis

Purinergic Signaling in Pulmonary Inflammation

Ventilation-induced epithelial injury drives biological onset of lung trauma in vitro and is mitigated with anti-inflammatory therapeutics

Ventilation-induced lung injury and mechanotransduction: stretching it too far?

Impact of Low and High Tidal Volumes on the Rat Alveolar Epithelial Type Ii Cell Proteome

Mitochondrial peptides cause proinflammatory responses in the alveolar epithelium via FPR-1, MAPKs, and AKT: a potential mechanism involved in acute lung injury.

Mitochondrial alarmins are tissue mediators of ventilator-induced lung injury and ARDS

Linking lung function and inflammatory responses in ventilator-induced lung injury

Ventilation‐induced epithelial injury drives biological onset of lung trauma in vitro and is mitigated with prophylactic anti‐inflammatory therapeutics

Respiratory viruses and the inflammasome: The double-edged sword of inflammation

Exuberant fibroblast activity compromises lung function via ADAMTS4

Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death

Mechanical ventilation enhances extrapulmonary sepsis-induced lung injury: role of WISP1–αvβ5 integrin pathway in TLR4-mediated inflammation and injury

Low-volume ventilation of preinjured lungs degrades lung function via stress concentration and progressive alveolar collapse

Mitochondrial Damage-Associated Molecular Patterns Exacerbate Lung Fluid Imbalance Via the Formyl Peptide Receptor-1 Signaling Pathway in Acute Lung Injury

Lytic Release of Cellular ATP: Physiological Relevance and Therapeutic Applications

SC5b-9-induced Pulmonary Microvascular Endothelial Hyperpermeability Participates in Ventilator-Induced Lung Injury.

P2X7 RECEPTOR PLAYS A CRUCIAL ROLE IN LPS‐MEDIATED ACUTE LUNG INJURY

Extracellular purines in lung endothelial permeability and pulmonary diseases

Macrophage-specific lipid nanoparticle therapy blocks the lungs mechanosensitive immunity due to macrophage-epithelial interactions